English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

One aspect of the recently published Nuffield Council on Bioethics’ report on Medical Profiling and Online Medicine centred on the development of direct-toconsumer (DTC) personal genomic services, and is the focus of Hood’s commentary in this issue of GSP. We have been prompted to make a number of comments in response to this piece (rather than to the report in its entirety). We would first like to state clearly that the work of the Nuffield group is welcomed and its report is a very useful contribution to ongoing discussions amongst academics, policy makers, and public interest groups about developments in the personalisation and online provision of various healthcare products and services.

A Response to Christopher Hood: 'The ethics of personal genetic profiling'